Back to trials
completed
Not Applicable

NCT02618876

Effect of Caudal Nalbuphine on Postoperative Analgesia in Children

Sponsored by Assiut University

Summary

Nalbuphine as an adjuvant to bupivacaine caudal anesthesia for postoperative analgesia in children undergoing Hypospadias repair. 2 groups, 30 patients each

Eligibility Criteria

Inclusion Criteria: * Children undergoing elective Hypospadias repair * with American Society of Anesthesiologists (ASA) physical status I * age 2-10 years Exclusion Criteria: * Coagulation disorder * allergy to study medications * major malformations of the lower spine or meninges or any cutaneous or subcutaneous lesion at the site of injection.

Locations (1)

Assiut University Hospital

Asyut, Egypt

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated4/7/2020
Clintriva indexed9/27/2026, 9:22:12 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateNov 1, 2015
CompletionDec 1, 2019
Enrollment0/60
CountryEgypt

Conditions

Postoperative Pain
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.